Park Ha Biological Technology Co., Ltd. (BYAH): R&D Expense
$238.2K
Year ended 2025-10-31
+57.8%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-10-31 | $238.2K | +548.8% | 2026-05-15, From 2024-11-01 |
| 2024-10-31 | $36.7K | +18.9% | 2026-05-15, From 2023-11-01 |
| 2023-10-31 | $30.9K | -49.1% | 2026-05-15, From 2022-11-01 |
| 2022-10-31 | $60.7K | n/a | 2025-02-24, From 2021-11-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Park Ha Biological Technology Co., Ltd. (BYAH) | 2025-10-31 | $238.2K | +548.8% |
| Longevity Health Holdings, Inc. (XAGE) | 2025-12-31 | $788.9K | -25.2% |
| Meiwu Technology Co Ltd (WNW) | 2025-12-31 | $2.69M | n/m |
| Stepan Co (SCL) | 2025-12-31 | $34.80M | +3.7% |
| Church & Dwight Co Inc (CHD) | 2025-12-31 | $145.60M | +4.2% |
| Ecolab Inc. (ECL) | 2025-12-31 | $202.00M | -2.4% |
| Procter & Gamble Co (PG) | 2026-06-30 | $2.10B | 0.0% |
Compare BYAH, XAGE, WNW, SCL side by side · Screen every company in Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics ↗